Clinical-Stage AI Platform
Advancing Therapies for Rare and Inflammatory Diseases
Inflammatory diseases like Acute Respiratory Distress Syndrome (ARDS), Cystic Fibrosis, Pneumonia, Bronchiolitis Obliterans, RSV, IPF, COPD, Asthma, Sepsis, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease and many other devastating diseases share a common p38 MAPK stress- and cytokine-activated kinases pathway which contributes to pathogenesis of these diseases.
These diseases cause suffering to millions of patients and families and cost society billions of dollars.
Our focus is on those inflammatory diseases which currently do not have effective treatment.